Shanghai, China

Qingbei Zeng

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Qingbei Zeng in Pharmaceutical Science

Introduction

Qingbei Zeng, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceutical science. With a portfolio that boasts nine patents, his work primarily focuses on developing compounds that target adenosine receptors associated with serious diseases, particularly various types of cancer.

Latest Patents

Among Qingbei Zeng's latest patents are innovative compounds that include:

1. **Triazolo-pyrimidine compounds and uses thereof**: This patent discloses novel triazolo-pyrimidine compounds that target adenosine receptors, specifically focusing on A1 and A2 receptors, with a particular emphasis on A2a. The pharmaceutical compositions derived from these compounds have significant potential in treating adenosine receptor-associated diseases, including non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), prostate cancer, and breast cancer.

2. **Pyrazine compounds and uses thereof**: This patent similarly focuses on novel pyrazine compounds that target adenosine receptors, again with a particular focus on the A2a receptor. The compositions made from these compounds aim to provide therapeutic options for the treatment of various adenosine receptor-associated diseases, including the same types of cancer mentioned in his triazolo-pyrimidine patent.

Career Highlights

Qingbei Zeng's career is marked by his tenure at AstraZeneca, a global biopharmaceutical company, where he applied his expertise in drug development. His innovative spirit and dedication to combating serious illnesses have positioned him as a prominent figure in the field of pharmaceutical research.

Collaborations

Throughout his career, Qingbei Zeng has collaborated with notable professionals, including Zhenfan Yang and Xiaolin Zhang. These partnerships highlight his commitment to advancing scientific knowledge and developing effective treatments for complex health issues.

Conclusion

In conclusion, Qingbei Zeng's contributions to pharmaceutical science through his innovative patents demonstrate his significant impact on the industry. His work in developing triazolo-pyrimidine and pyrazine compounds showcases his drive to address critical health challenges, particularly in the realm of cancer treatment. As he continues to advance his research, Qingbei Zeng remains a key figure in the ongoing battle against disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…